ZEAL and RPRX Related Headlines
Go Back- Zealand Pharma sells rusfertide royalty rights to Royalty Pharma for $100M
- Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide

